SCHEMBL9190227

SCHEMBL9190227

CCCc1cc(SC[Si](CC)(CC)CSc2cc(CCC)c(O)c(CCC)c2)cc(CCC)c1O

nearest known ligand 0.36

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
DHFR P00374 2/20 0.34
HMGCR P04035 1/20 0.33
ALOX5 P09917 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
PRKCI P41743 1/20 0.30
PTPN1 P18031 1/20 0.30
PTPN11 Q06124 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9193484 0.90 TYR (0.38) ALOX5
SCHEMBL9195084 0.86 GABRA1 (0.38) DHFR
SCHEMBL9190686 0.85 ALOX5 (0.33) DHFRHMGCRALOX5
SCHEMBL8573280 0.84 DHFR (0.35) DHFRHMGCRALOX5CNR1CNR2
SCHEMBL9193207 0.84 DHFR (0.35) DHFRHMGCRALOX5CNR1CNR2
SCHEMBL9193322 0.80 GABRA1 (0.42)
SCHEMBL9188546 0.79 TYR (0.37) ALOX5
SCHEMBL9193214 0.77 ESR1 (0.39) ALOX5
SCHEMBL8573273 0.75 ALOX5 (0.35) DHFRALOX5
SCHEMBL2678602 0.75 HMGCR (0.39) DHFRHMGCRALOX5CNR1CNR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0464844-B1 Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMA (US) 1995-12-27 EP disclosed
US-5304668-A Bis-[4-(2,6-di-alkyl)phenolisilane derivatives as antiatherosclerotic agents MERRELL DOW PHARMACEUTICALS (US) 1994-04-19 US disclosed
US-5281738-A Anticholesterol agents MERRELL DOW PHARMACEUTICALS INC. (US) 1994-01-25 US disclosed
EP-0464844-A1 Novel bis (4-(2,6-di-alkyl)phenol)silane derivatives as antiatherosclerotic agents and as antioxidants MERRELL DOW PHARMACEUTICALS INC. (US) 1992-01-08 EP disclosed